Literature DB >> 2114315

Serine phosphorylation of biosynthetic pro-urokinase from human tumor cells.

M R Mastronicola1, M P Stoppelli, A Migliaccio, F Auricchio, F Blasi.   

Abstract

Phosphorylation is a potent mechanism regulating the activity of many intracellular enzymes. We have discovered that the product of the human urokinase plasminogen activator gene, pro-uPA, is phosphorylated in serine in at least two human cell lines. Phosphorylation occurs within the cell during biosynthesis, and phosphorylated intracellular pro-uPA is secreted into the medium. Of the secreted pro-uPA molecules, 20-50% are phosphorylated in serine, thus representing a meaningful fraction of the total biosynthetic pro-uPA. Although the sites of phosphorylation have not yet been determined, at least two such sites must exist; in fact plasmin cleavage of phosphorylated single chain pro-uPA yields a two chain uPA in which both chains are phosphorylated. A specific function for pro-uPA phosphorylation has not yet been identified; however, it is tempting to speculate that, as in many other cases, phosphorylation may affect the activity of the enzyme, its response to inhibitors or the conversion of pro-uPA zymogen to active two-chain uPA. This would represent an additional way of regulating extracellular proteolysis, an important pathway involved in both intra- and extravascular phenomena like fibrinolysis, cell migration and invasiveness.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2114315     DOI: 10.1016/0014-5793(90)81519-t

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  2 in total

1.  Interaction of plasminogen with dipeptidyl peptidase IV initiates a signal transduction mechanism which regulates expression of matrix metalloproteinase-9 by prostate cancer cells.

Authors:  M Gonzalez-Gronow; H E Grenett; M R Weber; G Gawdi; S V Pizzo
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

2.  Phosphorylation of human pro-urokinase on Ser138/303 impairs its receptor-dependent ability to promote myelomonocytic adherence and motility.

Authors:  P Franco; C Iaccarino; F Chiaradonna; A Brandazza; C Iavarone; M R Mastronicola; M L Nolli; M P Stoppelli
Journal:  J Cell Biol       Date:  1997-05-05       Impact factor: 10.539

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.